Alkermes (ALKS) CCO granted options and RSUs, sells 6,000 shares at $30
Rhea-AI Filing Summary
Alkermes plc senior vice president and chief commercial officer Christian Todd Nichols reported both equity awards and a share sale. He received an employee stock option for 66,430 shares and a restricted stock unit award for 30,854 units, each at a grant price of $0.00 per share. Both the option and RSUs vest in four equal annual installments, starting on 3/2/2027. On the same date, he sold 6,000 ordinary shares at $30.00 per share in an open-market transaction effected under a pre-established Rule 10b5-1 trading plan adopted on 11/19/2025, and held 109,769 ordinary shares afterward.
Positive
- None.
Negative
- None.
Insights
Routine equity awards combined with a planned 10b5-1 sale; overall neutral.
The reporting person, a senior commercial executive at Alkermes plc, received sizable equity compensation on 3/2/2026: an option for 66,430 shares and 30,854 restricted stock units, both granted at $0.00. These awards vest in four equal annual installments starting on 3/2/2027, aligning incentives with longer-term company performance.
On the same date, he executed an open-market sale of 6,000 ordinary shares at $30.00 per share, totaling $180,000. A footnote states the sale was made under a Rule 10b5-1 trading plan adopted on 11/19/2025, indicating it was pre-arranged rather than opportunistic. After the sale, he retained 109,769 ordinary shares, alongside the newly granted options and RSUs.
The combination of long-vesting awards and a relatively modest, pre-planned sale suggests standard executive compensation and liquidity management. Future company filings may show how much of these awards ultimately vest and are exercised over the vesting period beginning in 2027.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Employee Stock Option (Right to Buy) | 66,430 | $0.00 | -- |
| Grant/Award | Restricted Stock Unit Award | 30,854 | $0.00 | -- |
| Sale | Ordinary Shares | 6,000 | $30.00 | $180K |
Footnotes (1)
- This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 11/19/2025. Shares underlying the stock option vest and become exercisable in four equal annual installments, commencing on 3/2/2027. Each restricted stock unit represents a contingent right to receive one ordinary share. Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 3/2/2027.